Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Is the Serviceaide Settlement Enough for 400,000 Victims?
Regulatory & Compliance Is the Serviceaide Settlement Enough for 400,000 Victims?

The digital landscape of modern medicine has transformed patient records into highly lucrative targets for cybercriminals who exploit the interconnected nature of third-party service providers. In the aftermath of a massive 2024 data breach that compromised the personal and medical records of over

Why Are Insurers Suing Over Medicare Advantage Star Ratings?
Infrastructure & Management Why Are Insurers Suing Over Medicare Advantage Star Ratings?

The annual release of Medicare Advantage star ratings has transformed from a routine administrative update into a high-stakes legal battlefield where billions of dollars in federal bonus payments hang in the balance for the nation's largest healthcare payers. These ratings, which range from one to

Can Humanoid Robots Revolutionize the Future of Surgery?
Infrastructure & Management Can Humanoid Robots Revolutionize the Future of Surgery?

The sight of a bipedal robot delicately manipulating surgical shears inside a patient might once have been confined to the realms of science fiction, yet recent clinical breakthroughs are transforming this vision into a tangible reality. Researchers at the University of California San Diego have

NHS Warns Staff of Prosecution for Snooping Into Patient Data
Regulatory & Compliance NHS Warns Staff of Prosecution for Snooping Into Patient Data

The sanctity of medical privacy has reached a critical tipping point as healthcare administrators across the United Kingdom issue stern warnings regarding the severe legal consequences awaiting any employee who accesses patient files without a legitimate clinical justification. In an era where

How Did Done Global Run a Massive Adderall Fraud Scheme?
Regulatory & Compliance How Did Done Global Run a Massive Adderall Fraud Scheme?

The recent sentencing of Ruthia He and David Brody has sent shockwaves through the healthcare technology sector, effectively ending a dark chapter defined by the reckless commodification of controlled substances. Done Global operated not as a patient-centered medical provider but as a sophisticated

Done Global Executives Sentenced for Illegal Stimulant Sales
Digital Health Done Global Executives Sentenced for Illegal Stimulant Sales

The rapid expansion of telehealth services once promised a frictionless future for mental health care, yet the recent sentencing of high-level executives from Done Global serves as a stark reminder of the legal and ethical boundaries that must govern digital medicine. When federal investigators

Trend Analysis: Congressional Healthcare Oversight
Regulatory & Compliance Trend Analysis: Congressional Healthcare Oversight

The long-standing period of quiet diplomacy between the medical establishment and Capitol Hill is rapidly dissolving as the 120th Congress prepares to turn its focus toward aggressive, public-facing investigations. This shift signals the definitive end of a relatively passive regulatory era,

Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?
Imaging & Diagnostics Can Non-Invasive Tests End the Endometriosis Diagnosis Wait?

For decades, the standard medical protocol for identifying endometriosis has required patients to undergo invasive laparoscopic surgery just to confirm a condition that affects nearly ten percent of the global female population during their reproductive years. This diagnostic bottleneck has

Medtronic Breach Reveals Growing Medtech Cybersecurity Risks
Regulatory & Compliance Medtronic Breach Reveals Growing Medtech Cybersecurity Risks

The convergence of digital infrastructure and critical patient care has transformed the modern medical technology landscape into a high-stakes environment where data security is now as vital as the clinical efficacy of the devices themselves. Following the discovery of unauthorized access to its

APA Launches Digital Badge Program for Mental Health Apps
Regulatory & Compliance APA Launches Digital Badge Program for Mental Health Apps

Navigating the sprawling landscape of over twenty thousand mental health applications currently available on major digital storefronts has become an overwhelming challenge for both patients seeking relief and clinicians aiming to provide evidence-based recommendations. For years, the absence of a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later